List of Tables
Table 1. Global Bio-based AN Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Bio-based AN Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Bio-based AN Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Bio-based AN Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Bio-based AN Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Bio-based AN Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
Table 7. Global Bio-based AN Sales by Region (2020-2025) & (Tons)
Table 8. Global Bio-based AN Sales by Region (2026-2031) & (Tons)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Bio-based AN Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
Table 11. Global Bio-based AN Production by Region (2020-2025) & (Tons)
Table 12. Global Bio-based AN Production by Region (2026-2031) & (Tons)
Table 13. Global Bio-based AN Sales by Manufacturers (2020-2025) & (Tons)
Table 14. Global Bio-based AN Sales Share by Manufacturers (2020-2025)
Table 15. Global Bio-based AN Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 16. Global Bio-based AN Revenue Market Share by Manufacturers (2020-2025)
Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 18. Global Bio-based AN by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bio-based AN as of 2024)
Table 19. Global Bio-based AN Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 20. Global Bio-based AN Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/kg)
Table 21. Key Manufacturers Bio-based AN Manufacturing Base and Headquarters
Table 22. Global Bio-based AN Market Concentration Ratio (CR5 and HHI)
Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 25. Global Bio-based AN Sales by Type (2020-2025) & (Tons)
Table 26. Global Bio-based AN Sales by Type (2026-2031) & (Tons)
Table 27. Global Bio-based AN Revenue by Type (2020-2025) & (US$ Million)
Table 28. Global Bio-based AN Revenue by Type (2026-2031) & (US$ Million)
Table 29. Global Bio-based AN ASP by Type (2020-2031) & (US$/kg)
Table 30. Technical Specifications by Key Product Type
Table 31. Global Bio-based AN Sales by Application (2020-2025) & (Tons)
Table 32. Global Bio-based AN Sales by Application (2026-2031) & (Tons)
Table 33. Bio-based AN High-Growth Sectors Demand CAGR (2024-2031)
Table 34. Global Bio-based AN Revenue by Application (2020-2025) & (US$ Million)
Table 35. Global Bio-based AN Revenue by Application (2026-2031) & (US$ Million)
Table 36. Global Bio-based AN ASP by Application (2020-2031) & (US$/kg)
Table 37. Top Customers by Region
Table 38. Top Customers by Application
Table 39. North America Bio-based AN Growth Accelerators and Market Barriers
Table 40. North America Bio-based AN Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 41. North America Bio-based AN Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 42. Europe Bio-based AN Growth Accelerators and Market Barriers
Table 43. Europe Bio-based AN Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 44. Europe Bio-based AN Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 45. Asia-Pacific Bio-based AN Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Asia-Pacific Bio-based AN Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 47. Asia-Pacific Bio-based AN Growth Accelerators and Market Barriers
Table 48. Southeast Asia Bio-based AN Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 49. Central and South America Bio-based AN Investment Opportunities and Key Challenges
Table 50. Central and South America Bio-based AN Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 51. Middle East and Africa Bio-based AN Investment Opportunities and Key Challenges
Table 52. Middle East and Africa Bio-based AN Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 53. Trillium Renewable Chemicals Corporation Information
Table 54. Trillium Renewable Chemicals Description and Major Businesses
Table 55. Trillium Renewable Chemicals Product Models, Descriptions and Specifications
Table 56. Trillium Renewable Chemicals Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 57. Trillium Renewable Chemicals Sales Value Proportion by Product in 2024
Table 58. Trillium Renewable Chemicals Sales Value Proportion by Application in 2024
Table 59. Trillium Renewable Chemicals Sales Value Proportion by Geographic Area in 2024
Table 60. Trillium Renewable Chemicals Bio-based AN SWOT Analysis
Table 61. Trillium Renewable Chemicals Recent Developments
Table 62. AnQore (Econitrile) Corporation Information
Table 63. AnQore (Econitrile) Description and Major Businesses
Table 64. AnQore (Econitrile) Product Models, Descriptions and Specifications
Table 65. AnQore (Econitrile) Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 66. AnQore (Econitrile) Sales Value Proportion by Product in 2024
Table 67. AnQore (Econitrile) Sales Value Proportion by Application in 2024
Table 68. AnQore (Econitrile) Sales Value Proportion by Geographic Area in 2024
Table 69. AnQore (Econitrile) Bio-based AN SWOT Analysis
Table 70. AnQore (Econitrile) Recent Developments
Table 71. Asahi Kasei Corporation Information
Table 72. Asahi Kasei Description and Major Businesses
Table 73. Asahi Kasei Product Models, Descriptions and Specifications
Table 74. Asahi Kasei Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 75. Asahi Kasei Sales Value Proportion by Product in 2024
Table 76. Asahi Kasei Sales Value Proportion by Application in 2024
Table 77. Asahi Kasei Sales Value Proportion by Geographic Area in 2024
Table 78. Asahi Kasei Bio-based AN SWOT Analysis
Table 79. Asahi Kasei Recent Developments
Table 80. INEOS Nitriles Corporation Information
Table 81. INEOS Nitriles Description and Major Businesses
Table 82. INEOS Nitriles Product Models, Descriptions and Specifications
Table 83. INEOS Nitriles Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 84. INEOS Nitriles Sales Value Proportion by Product in 2024
Table 85. INEOS Nitriles Sales Value Proportion by Application in 2024
Table 86. INEOS Nitriles Sales Value Proportion by Geographic Area in 2024
Table 87. INEOS Nitriles Bio-based AN SWOT Analysis
Table 88. INEOS Nitriles Recent Developments
Table 89. Key Raw Materials Distribution
Table 90. Raw Materials Key Suppliers
Table 91. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 92. Milestones in Production Technology Evolution
Table 93. Distributors List
Table 94. Market Trends and Market Evolution
Table 95. Market Drivers and Opportunities
Table 96. Market Challenges, Risks, and Restraints
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Bio-based AN Product Picture
Figure 2. Global Bio-based AN Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Biological Route Product Picture
Figure 4. Hybrid Route Product Picture
Figure 5. Global Bio-based AN Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Plastics
Figure 7. Rubber
Figure 8. Carbon Fiber
Figure 9. Others
Figure 10. Bio-based AN Report Years Considered
Figure 11. Global Bio-based AN Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Bio-based AN Revenue (2020-2031) & (US$ Million)
Figure 13. Global Bio-based AN Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Bio-based AN Revenue Market Share by Region (2020-2031)
Figure 15. Global Bio-based AN Sales (2020-2031) & (Tons)
Figure 16. Global Bio-based AN Sales (CAGR) by Region (2020-2031) (Tons)
Figure 17. Global Bio-based AN Sales Market Share by Region (2020-2031)
Figure 18. Global Bio-based AN Capacity, Production and Utilization (2020-2031) & (Tons)
Figure 19. Global Bio-based AN Production Trend by Region (2020-2031) (Tons)
Figure 20. Global Bio-based AN Production Market Share by Region (2020-2031)
Figure 21. Production Capacity Enablers & Constraints
Figure 22. Bio-based AN Production Growth Rate in North America (2020-2031) & (Tons)
Figure 23. Bio-based AN Production Growth Rate in Europe (2020-2031) & (Tons)
Figure 24. Bio-based AN Production Growth Rate in China (2020-2031) & (Tons)
Figure 25. Bio-based AN Production Growth Rate in Japan (2020-2031) & (Tons)
Figure 26. Top 5 and Top 10 Manufacturers Bio-based AN Sales Volume Market Share in 2024
Figure 27. Global Bio-based AN Revenue Market Share Ranking (2024)
Figure 28. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 29. Biological Route Revenue Market Share by Manufacturer in 2024
Figure 30. Hybrid Route Revenue Market Share by Manufacturer in 2024
Figure 31. Type Eight Revenue Market Share by Manufacturer in 2024
Figure 32. Type Nine Revenue Market Share by Manufacturer in 2024
Figure 33. Global Bio-based AN Sales Market Share by Type (2020-2031)
Figure 34. Global Bio-based AN Revenue Market Share by Type (2020-2031)
Figure 35. Global Bio-based AN Sales Market Share by Application (2020-2031)
Figure 36. Global Bio-based AN Revenue Market Share by Application (2020-2031)
Figure 37. North America Bio-based AN Sales YoY (2020-2031) & (Tons)
Figure 38. North America Bio-based AN Revenue YoY (2020-2031) & (US$ Million)
Figure 39. North America Top 5 Manufacturers Bio-based AN Sales Revenue (US$ Million) in 2024
Figure 40. North America Bio-based AN Sales Volume (Tons) by Type (2020- 2031)
Figure 41. North America Bio-based AN Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 42. North America Bio-based AN Sales Volume (Tons) by Application (2020-2031)
Figure 43. North America Bio-based AN Sales Revenue (US$ Million) by Application (2020-2031)
Figure 44. US Bio-based AN Revenue (2020-2031) & (US$ Million)
Figure 45. Canada Bio-based AN Revenue (2020-2031) & (US$ Million)
Figure 46. Mexico Bio-based AN Revenue (2020-2031) & (US$ Million)
Figure 47. Europe Bio-based AN Sales YoY (2020-2031) & (Tons)
Figure 48. Europe Bio-based AN Revenue YoY (2020-2031) & (US$ Million)
Figure 49. Europe Top 5 Manufacturers Bio-based AN Sales Revenue (US$ Million) in 2024
Figure 50. Europe Bio-based AN Sales Volume (Tons) by Type (2020-2031)
Figure 51. Europe Bio-based AN Sales Revenue (US$ Million) by Type (2020-2031)
Figure 52. Europe Bio-based AN Sales Volume (Tons) by Application (2020-2031)
Figure 53. Europe Bio-based AN Sales Revenue (US$ Million) by Application (2020-2031)
Figure 54. Germany Bio-based AN Revenue (2020-2031) & (US$ Million)
Figure 55. France Bio-based AN Revenue (2020-2031) & (US$ Million)
Figure 56. U.K. Bio-based AN Revenue (2020-2031) & (US$ Million)
Figure 57. Italy Bio-based AN Revenue (2020-2031) & (US$ Million)
Figure 58. Russia Bio-based AN Revenue (2020-2031) & (US$ Million)
Figure 59. Asia-Pacific Bio-based AN Sales YoY (2020-2031) & (Tons)
Figure 60. Asia-Pacific Bio-based AN Revenue YoY (2020-2031) & (US$ Million)
Figure 61. Asia-Pacific Top 8 Manufacturers Bio-based AN Sales Revenue (US$ Million) in 2024
Figure 62. Asia-Pacific Bio-based AN Sales Volume (Tons) by Type (2020- 2031)
Figure 63. Asia-Pacific Bio-based AN Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 64. Asia-Pacific Bio-based AN Sales Volume (Tons) by Application (2020-2031)
Figure 65. Asia-Pacific Bio-based AN Sales Revenue (US$ Million) by Application (2020-2031)
Figure 66. Indonesia Bio-based AN Revenue (2020-2031) & (US$ Million)
Figure 67. Japan Bio-based AN Revenue (2020-2031) & (US$ Million)
Figure 68. South Korea Bio-based AN Revenue (2020-2031) & (US$ Million)
Figure 69. China Taiwan Bio-based AN Revenue (2020-2031) & (US$ Million)
Figure 70. India Bio-based AN Revenue (2020-2031) & (US$ Million)
Figure 71. Central and South America Bio-based AN Sales YoY (2020-2031) & (Tons)
Figure 72. Central and South America Bio-based AN Revenue YoY (2020-2031) & (US$ Million)
Figure 73. Central and South America Top 5 Manufacturers Bio-based AN Sales Revenue (US$ Million) in 2024
Figure 74. Central and South America Bio-based AN Sales Volume (Tons) by Type (2021-2031)
Figure 75. Central and South America Bio-based AN Sales Revenue (US$ Million) by Type (2020-2031)
Figure 76. Central and South America Bio-based AN Sales Volume (Tons) by Application (2020-2031)
Figure 77. Central and South America Bio-based AN Sales Revenue (US$ Million) by Application (2020-2031)
Figure 78. Brazil Bio-based AN Revenue (2020-2025) & (US$ Million)
Figure 79. Argentina Bio-based AN Revenue (2020-2025) & (US$ Million)
Figure 80. Middle East, and Africa Bio-based AN Sales YoY (2020-2031) & (Tons)
Figure 81. Middle East and Africa Bio-based AN Revenue YoY (2020-2031) & (US$ Million)
Figure 82. Middle East and Africa Top 5 Manufacturers Bio-based AN Sales Revenue (US$ Million) in 2024
Figure 83. Middle East and Africa Bio-based AN Sales Volume (Tons) by Type (2021-2031)
Figure 84. South America Bio-based AN Sales Revenue (US$ Million) by Type (2020-2031)
Figure 85. Middle East and Africa Bio-based AN Sales Volume (Tons) by Application (2020-2031)
Figure 86. Middle East and Africa Bio-based AN Sales Revenue (US$ Million) by Application (2020-2031)
Figure 87. GCC Countries Bio-based AN Revenue (2020-2025) & (US$ Million)
Figure 88. Turkey Bio-based AN Revenue (2020-2025) & (US$ Million)
Figure 89. Egypt Bio-based AN Revenue (2020-2025) & (US$ Million)
Figure 90. South Africa Bio-based AN Revenue (2020-2025) & (US$ Million)
Figure 91. Bio-based AN Industry Chain Mapping
Figure 92. Regional Bio-based AN Manufacturing Base Distribution (%)
Figure 93. Bio-based AN Production Process
Figure 94. Regional Bio-based AN Production Cost Structure
Figure 95. Channels of Distribution (Direct Vs Distribution)
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed